v3.26.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 49,980 $ 26,962
Restricted cash 718 575
Customer funds 20,582 14,662
Investments 311 235
Accounts receivable, net 11,276 12,070
Prepaid insurance 924 2,749
Other current assets 13,609 14,947
Total current assets 97,400 72,200
Property, equipment and software, net 2,085 1,660
Goodwill 156,690 64,658
Intangible assets 22,862 5,550
Equity method investment 10,645 11,149
Derivative asset 0 3,352
Transchem Warrants 107,906 0
Other assets 6,012 4,219
Total assets 403,600 162,788
Current liabilities:    
Accounts payable and accrued liabilities 9,847 14,876
Customer funds payable 20,582 14,662
Deferred revenue, current 0 789
Other current liabilities 591 2,703
Total current liabilities 31,020 33,030
Warrant liability 10,616 16,732
Other noncurrent liabilities 7,574 244
Total liabilities 49,210 50,006
Commitments and contingencies (Note 17)
Common stock, value 4 3
Additional paid-in capital 1,189,365 1,017,004
Accumulated other comprehensive loss 1,001 947
Accumulated deficit (835,980) (905,172)
Total equity 354,390 112,782
Total liabilities and equity $ 403,600 $ 162,788